Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Tob Prev Cessat ; 7: 54, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34327287

RESUMO

INTRODUCTION: Limited research has explored sex differences in the relationship between partner support and smoking cessation among minority low-income population. Further, scarce attention has been given to the influence of partners who are not married. The purpose of this study is to examine the relationship between negative and positive social support provided by partners and smoking cessation among men and women smokers. METHODS: Data were collected as part of the Tobacco Use in Drug Environment (TIDE) study, a cross-sectional study conducted in Baltimore, Maryland, from September 2013 to May 2015. Interviews were administered with current smokers. The sample size for the current analysis was 134 men and 86 women. RESULTS: Approximately 33% of male participants (n=45) reported currently trying to quit smoking cigarettes and 29% of women were currently trying to quit. Having a sex partner who did not mind the participant's smoking was associated with decreased odds of trying to quit among men (AOR=0.35; 95% CI: 0.13-0.91, p=0.03). Having a sex partner who expressed concern about the participant's smoking (AOR=12.9; 95% CI: 3.49-47.0, p<0.01) and having a sex partner who encouraged the participant to quit smoking was significantly associated with current quit attempt among women. In supplementary analyses, we found that each type of partner support varied based on the type of partner - committed or casual. CONCLUSIONS: Understanding sex-partner support regarding smoking and their relationship to smoking cessation activities may provide insights for future tailored cessation interventions.

2.
Health Educ Res ; 36(3): 261-271, 2021 07 12.
Artigo em Inglês | MEDLINE | ID: mdl-33667311

RESUMO

Amid the COVID-19 pandemic, TikTok, an emerging social media platform, has created an information hub to provide users with engaging and authoritative COVID-19 information. This study investigates the video format, type and content of the COVID-19 TikTok videos, and how those video attributes are related to quantitative indicators of user engagement, including numbers of views, likes, comments and shares. A content analysis examined 331 videos from official accounts featured in the COVID-19 information hub. As of 5 May 2020, the videos received 907 930 000 views, 29 640 000 likes, 168 880 comments and 781 862 shares. About one in three videos had subtitles, which were positively related to the number of shares. Almost every video included a hashtag, and a higher number of hashtags was related to more likes. Video types included acting, animated infographic, documentary, news, oral speech, pictorial slideshow and TikTok dance. Dance videos had the most shares. Video themes included anti-stigma/anti-rumor, disease knowledge, encouragement, personal precautions, recognition, societal crisis management and work report. Videos conveying alarm/concern emotions, COVID-19 susceptibility and severity, precaution response efficacy had higher user engagement. Public health agencies should be aware of the opportunity of TikTok in health communication and create audience-centered risk communication to engage and inform community members.


Assuntos
COVID-19 , Comunicação em Saúde , Mídias Sociais , Humanos , Pandemias , SARS-CoV-2
3.
Subst Abuse ; 12: 1178221818799753, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30210233

RESUMO

Among 100 people who inject drugs enrolled in a peer mentorship intervention aiming to promote injection-related risk reduction behavior change, we evaluated the role of participation in a dyad session on reducing sharing of syringes and cookers in the past 6 months. Dyad participants (n = 69) invited an injection, sex partner, or family member to the study site to reinforce learnt behavior change tools by practicing communication skills and risk reduction lessons. In all, 31 participants did not participate in the dyad session. We descriptively assessed changes in sharing injection equipment between the 2 time points of pre- and postintervention using the tests of proportions by dyad participation. Multivariable logistic regression adjusted for sex was used with an interaction term (time points × dyad participation) to evaluate the dyad effect. Dyad participants reported reduced syringe and cooker sharing at postintervention (sharing syringe: 17% versus 39%, P < .05 and cooker: 32% versus 59%, P < .01). There was no difference between the dyad group's sharing injection equipment behavior after the intervention (sharing syringes: adjusted odds ratio [aOR] 0.76; 95% confidence interval [CI] 0.1-3.9 and cookers: aOR 0.72; 95% CI 0.1-3.5). The role of the dyad session alone on risk taking was not effective. With a small sample size, it is important to continue to evaluate the nature of peer-based dyadic experiences in future studies.

4.
PLoS One ; 13(1): e0190487, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29304154

RESUMO

Challenges with adherence to daily oral antiretroviral therapy (ART) among people living with HIV (PLHIV) have stimulated development of injectable long-acting (LA) regimens. We conducted 39 in-depth interviews with participants and providers in a Phase IIb study (LATTE-2) evaluating an injectable LA regimen in the U.S. and Spain. Interviews exploring participant and provider attitudes and experiences with LA versus oral ART were audiotaped, transcribed and analyzed using thematic content analysis. Participants described the convenience of LA injections versus daily pills and emotional benefits such as minimized potential for HIV disclosure and eliminating the "daily reminder of living with HIV." Providers recognized benefits but cautioned that LA candidates still need to adhere to clinic visits for injections and raised questions around ongoing clinical management. LA was seen as preferable to daily oral ART among PLHIV. Further research is needed regarding appropriate candidates, including with women and "non-adherent" populations across settings.


Assuntos
Fármacos Anti-HIV/administração & dosagem , Infecções por HIV/tratamento farmacológico , Piridonas/uso terapêutico , Rilpivirina/uso terapêutico , Humanos , Piridonas/administração & dosagem , Pesquisa Qualitativa , Rilpivirina/administração & dosagem , Espanha , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...